Widemann, B C <br/><br/>
Carboxypeptidase-G2, thymidine, and leucovorin rescue in cancer patients with methotrexate-induced renal dysfunction.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  May 1997 
 - 2125-34 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>0732-183X 
<br/><br/><label>Standard No.: </label>10.1200/JCO.1997.15.5.2125  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Antidotes--therapeutic use<br/>Antimetabolites, Antineoplastic--administration & dosage<br/>Carboxypeptidases--adverse effects<br/>Child<br/>Child, Preschool<br/>Female<br/>Humans<br/>Infant<br/>Kidney--drug effects<br/>Kidney Diseases--chemically induced<br/>Leucovorin--therapeutic use<br/>Lymphoma, Non-Hodgkin--blood<br/>Male<br/>Methotrexate--administration & dosage<br/>Middle Aged<br/>Precursor Cell Lymphoblastic Leukemia-Lymphoma--blood<br/>Sarcoma--blood<br/>Thymidine--adverse effects